Publications by authors named "Anna Cseh"

Claim this Profile
A
Amiodarone's major metabolite, desethylamiodarone inhibits proliferation of B16-F10 melanoma cells and limits lung metastasis formation in an in vivo experimental model.
Zita Bognar, Anna Maria Cseh, Katalin Fekete, Csenge Antus, Rita Bognar

PLoS One· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells.
Anna Maria Cseh, Zsolt Fabian, Ruben Quintana-Cabrera, Aliz Szabo, Krisztian Eros

Front Physiol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly(adenosine diphosphate-ribose) polymerase as therapeutic target: lessons learned from its inhibitors.
Anna Mária Cseh, Zsolt Fábián, Balázs Sümegi, Luca Scorrano

Oncotarget· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway.
Eniko Hocsak, Viktor Szabo, Nikoletta Kalman, Csenge Antus, Anna Cseh

Free Radic Biol Med· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP inhibitor attenuated colony formation can be restored by MAP kinase inhibitors in different irradiated cancer cell lines.
Eniko Hocsak, Anna Cseh, Aliz Szabo, Szabolcs Bellyei, Eva Pozsgai

Int J Radiat Biol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quercetin increases the efficacy of glioblastoma treatment compared to standard chemoradiotherapy by the suppression of PI-3-kinase-Akt pathway.
Eva Pozsgai, Szabolcs Bellyei, Anna Cseh, Arpad Boronkai, Boglarka Racz

Nutr Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam.
Mária Tóth, Sándor Drabant, Bálint Varga, Gyula Végso, Anna Cseh

Eur J Clin Pharmacol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis